In the 72-week SURMOUNT-1 trial published by Jastreboff and colleagues in the New England Journal of Medicine , adults without type 2 diabetes who received once-weekly subcutaneous tirzepatide achieved mean body-weight reductions of 15.0%, 19.5%, and 20.9% at the 5 mg, 10 mg, and 15 mg amounts respectively, compared with 3.1% in the placebo group [1]
At our Lewisville, TX medical clinic , we offer comprehensive consultations to determine if Qsymia is a suitable option for your weight management journey
The number of sessions required depends on your present skin color, the outcome to be achieved and the state of your skin
With regular use, youll notice softer, smoother skin with a brighter and healthier look
Last Updated On 21 Jan
May your dosages stay accurate, your titration stay gradual, and your results stay consistent.